2-[4-(1H-imidazol-1-yl)butoxy]benzaldehyde hydrochloride, 95.0%, 1g

3-Ethoxy-2,2-dimethyl-3-oxopropanoic acid, 95.0%, 25g

1,6-Anhydro-beta-d-glucose, 99.0%, 25g

Dimethyl({[(3S)-pyrrolidin-3-yl]methyl})amine dihydrochloride, 97%, 500mg

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95.0%, 1g

2,5-Dibromo-4-methylpyrimidine, 95.0%, 10g

Ethyl 2-bromo-5-methylthiazole-4-carboxylate, 95.0%, 1g

4-(4-tert-Butylphenyl)-4-oxobutyric acid, 95.0%, 10g

n-Cyclopropylpyridin-4-amine, 95%, 1g

Hydrochloric acid, ROTI®Volum 0.5 mol/l - 0.5 N, ampoule, 1 piece, plastic packaging.

1-Cyclopropylnaphthalene, 95.0%, 25g

4-Bromobutan-2-one, 95%, 1g